Form D · Biotechnology
NERVEDA LLC
San Diego, CA · CIK 0001404543
Offering snapshot reported Aug 3, 2011 · SEC filing
- Reported sold
- $3.9M Offering amount: $7.78M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 22, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 3, 2011 | Initial | $3,899,510 | No comparison | 36 | SEC filing |
| Apr 12, 2010 | Amendment | $14,135,454 | No comparison | 55 | SEC filing |
| Jun 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-163893
Source: Form D, filed Aug 3, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rob Ades | Director |
| Adam Cohen | Director |
| Cam Gallagher | Director, Executive, Promoter |
| Odo Habeck | Director |
| Thomas Lionelli | Director |
| David Maurer Hollaender | Director |
| Stewart Reid | Director |
| James Weil | Director |
| Debra Widmann | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3888 Quarter Mile Drive
San Diego, CA, 92130
San Diego, CA, 92130